Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance

Journal of Hepatology

Volumn 61, Issue 6, 2014, Pages 1385-1396

  Albillos, Agustín ^a,b,c   Lario, Margaret ^a   Álvarez Mon, Melchor ^a,b,d  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

Immune response; Immunodeficiency; Inflammation; Lipopolysaccharide; T cytotoxic; T helper

Indexed keywords

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; DECOMPENSATED LIVER CIRRHOSIS; DENDRITIC CELL; ENDOTHELIUM CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; INNATE IMMUNITY; INTESTINE LYMPHATIC TISSUE; KUPFFER CELL; LIVER CELL DAMAGE; LIVER CIRRHOSIS; MONOCYTE; NEUTROPHIL; PATHOGENESIS; PATTERN RECOGNITION; PHENOTYPE; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW; T LYMPHOCYTE; DISEASE PREDISPOSITION; HEMODYNAMICS; HOMEOSTASIS; IMMUNE SYSTEM; INFLAMMATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

DISEASE SUSCEPTIBILITY; HEMODYNAMICS; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; LIVER CIRRHOSIS; PHENOTYPE;

EID: 84922772130     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.08.010     Document Type: Review

References (133)

1. R. Jalan, J. Fernandez, R. Wiest, B. Schnabl, R. Moreau, and P. Angeli Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013 J Hepatol 60 2014 1310 1324
2. E.B. Keeffe, S. Iwarson, B.J. McMahon, K.L. Lindsay, R.S. Koff, and M. Manns Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease Hepatology 27 1998 881 886
3. E.B. Keeffe, and D.S. Krause Hepatitis B vaccination of patients with chronic liver disease Liver Transpl Surg 4 1998 437 439
4. C.N. Jenne, and P. Kubes Immune surveillance by the liver Nat Immunol 14 2013 996 1006
5. A.W. Thomson, and P.A. Knolle Antigen-presenting cell function in the tolerogenic liver environment Nat Rev Immunol 10 2010 753 766
6. V. Racanelli, and B. Rehermann The liver as an immunological organ Hepatology 43 2006 S54 62
7. S.H. Gregory, L.P. Cousens, N. van Rooijen, E.A. Dopp, T.M. Carlos, and E.J. Wing Complementary adhesion molecules promote neutrophil-Kupffer cell interaction and the elimination of bacteria taken up by the liver J Immunol 168 2002 308 315
8. B. Smedsrod, H. Pertoft, S. Gustafson, and T.C. Laurent Scavenger functions of the liver endothelial cell Biochem J 266 1990 313 327
9. F.L. Willekens, J.M. Werre, J.K. Kruijt, B. Roerdinkholder-Stoelwinder, Y.A. Groenen-Dopp, and A.G. van den Bos Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors Blood 105 2005 2141 2145
10. S.H. Gregory, A.J. Sagnimeni, and E.J. Wing Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils J Immunol 157 1996 2514 2520
11. V.G. Pillarisetty, A.B. Shah, G. Miller, J.I. Bleier, and R.P. DeMatteo Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition J Immunol 172 2004 1009 1017
12. F.A. Schildberg, S.I. Hegenbarth, B. Schumak, K. Scholz, A. Limmer, and P.A. Knolle Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells Eur J Immunol 38 2008 957 967
13. Q. You, L. Cheng, R.M. Kedl, and C. Ju Mechanism of T cell tolerance induction by murine hepatic Kupffer cells Hepatology 48 2008 978 990
14. J.D. Ellett, C. Atkinson, Z.P. Evans, Z. Amani, E. Balish, and M.G. Schmidt Murine Kupffer cells are protective in total hepatic ischemia/reperfusion injury with bowel congestion through IL-10 J Immunol 184 2010 5849 5858
15. B. Gao, W.I. Jeong, and Z. Tian Liver: an organ with predominant innate immunity Hepatology 47 2008 729 736
16. G. Ramadori, and B. Christ Cytokines and the hepatic acute-phase response Semin Liver Dis 19 1999 141 155
17. C. Liu, Z. Xu, D. Gupta, and R. Dziarski Peptidoglycan recognition proteins: a novel family of four human innate immunity pattern recognition molecules J Biol Chem 276 2001 34686 34694
18. I.N. Crispe The liver as a lymphoid organ Annu Rev Immunol 27 2009 147 163
19. K.Y. Helmy, K.J. Katschke Jr., N.N. Gorgani, N.M. Kljavin, J.M. Elliott, and L. Diehl CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens Cell 124 2006 915 927
20. A. Rimola, R. Soto, F. Bory, V. Arroyo, C. Piera, and J. Rodes Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis Hepatology 4 1984 53 58
21. B.A. Runyon, R.L. Morrissey, J.C. Hoefs, and F.A. Wyle Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis Hepatology 5 1985 634 637
22. B.A. Runyon Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis Hepatology 8 1988 632 635
23. L.H. Bouwman, A. Roos, O.T. Terpstra, P. de Knijff, B. van Hoek, and H.W. Verspaget Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation Gastroenterology 129 2005 408 414
24. I. Altorjay, Z. Vitalis, I. Tornai, K. Palatka, S. Kacska, and G. Farkas Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis J Hepatol 53 2010 484 491
25. I.A. Rajkovic, and R. Williams Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis Hepatology 6 1986 252 262
26. C. Fiuza, M. Salcedo, G. Clemente, and J.M. Tellado In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease J Infect Dis 182 2000 526 533
27. G. Tritto, Z. Bechlis, V. Stadlbauer, N. Davies, R. Frances, and N. Shah Evidence of neutrophil functional defect despite inflammation in stable cirrhosis J Hepatol 55 2011 574 581
28. Y. Ono, T. Watanabe, K. Matsumoto, T. Ito, O. Kunii, and E. Goldstein Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-α and lipopolysaccharide in patients' blood J Infect Chemother 10 2004 200 207
29. L. Rolas, N. Makhezer, S. Hadjoudj, J. El-Benna, B. Djerdjouri, and L. Elkrief Inhibition of mammalian target of rapamycin aggravates the respiratory burst defect of neutrophils from decompensated patients with cirrhosis Hepatology 57 2013 1163 1171
30. C. Garfia, I. Garcia-Ruiz, and J.A. Solis-Herruzo Deficient phospholipase C activity in blood polimorphonuclear neutrophils from patients with liver cirrhosis J Hepatol 40 2004 749 756
31. C. Fiuza, M. Salcedo, G. Clemente, and J.M. Tellado Granulocyte colony-stimulating factor improves deficient in vitro neutrophil transendothelial migration in patients with advanced liver disease Clin Diagn Lab Immunol 9 2002 433 439
32. H.W. Zimmermann, S. Seidler, J. Nattermann, N. Gassler, C. Hellerbrand, and A. Zernecke Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis PLoS One 2010 5e11049
33. S. Seidler, H.W. Zimmermann, R. Weiskirchen, C. Trautwein, and F. Tacke Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes BMC Gastroenterol 12 2012 38
34. A. Albillos, L. Hera Ad Ade, E. Reyes, J. Monserrat, L. Munoz, and M. Nieto Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin J Hepatol 40 2004 624 631
35. F. Gomez, P. Ruiz, and A.D. Schreiber Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis N Engl J Med 331 1994 1122 1128
36. R.T. Cook, T.J. Waldschmidt, B.L. Cook, D.R. Labrecque, and K. McLatchie Loss of the CD5+ and CD45RAhi B cell subsets in alcoholics Clin Exp Immunol 103 1996 304 310
37. F.J. Laso, J.I. Madruga, A. Lopez, J. Ciudad, M. Alvarez-Mon, and J. San Miguel Distribution of peripheral blood lymphoid subsets in alcoholic liver cirrhosis: influence of ethanol intake Alcohol Clin Exp Res 20 1996 1564 1568
38. B. Massonnet, A. Delwail, J.M. Ayrault, C. Chagneau-Derrode, J.C. Lecron, and C. Silvain Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Toll-like receptor 9 activation Clin Exp Immunol 158 2009 115 124
39. H. Doi, T.K. Iyer, E. Carpenter, H. Li, K.M. Chang, and R.H. Vonderheide Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population Hepatology 55 2012 709 719
40. D. Perrin, J.D. Bignon, E. Beaujard, and M.L. Cheneau Populations of circulating T lymphocytes in patients with alcoholic cirrhosis Gastroenterol Clin Biol 8 1984 907 910
41. K. Morita, Y. Fukuda, I. Nakano, Y. Katano, and T. Hayakawa Peripheral lymphocyte subsets vary with stage of hepatitis C virus-associated liver disease Hepatogastroenterology 52 2005 1803 1808
42. B.H. McGovern, Y. Golan, M. Lopez, D. Pratt, A. Lawton, and G. Moore The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients Clin Infect Dis 44 2007 431 437
43. M. Lario, L. Munoz, M. Ubeda, M.J. Borrero, J. Martinez, and J. Monserrat Defective thymopoiesis and poor peripheral homeostatic replenishment of T-helper cells cause T-cell lymphopenia in cirrhosis J Hepatol 59 2013 723 730
44. N.L. Yonkers, S. Sieg, B. Rodriguez, and D.D. Anthony Reduced naive CD4 T cell numbers and impaired induction of CD27 in response to T cell receptor stimulation reflect a state of immune activation in chronic hepatitis C virus infection J Infect Dis 203 2011 635 645
45. J. Deviere, C. Denys, L. Schandene, F. Romasco, M. Adler, and J. Wybran Decreased proliferative activity associated with activation markers in patients with alcoholic liver cirrhosis Clin Exp Immunol 72 1988 377 382
46. J.A. Giron-Gonzalez, M. Alvarez-Mon, J.L. Menendez-Caro, L. Manzano, L. Abreu, and M. Yebra T lymphocytes from alcoholic cirrhotic patients show normal interleukin-2 production but a defective proliferative response to polyclonal mitogens Am J Gastroenterol 89 1994 767 773
47. C. Morishima, A.M. Di Bisceglie, A.L. Rothman, H.L. Bonkovsky, K.L. Lindsay, and W.M. Lee Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C J Viral Hepat 19 2012 404 413
48. F.J. Laso, J.I. Madruga, J.A. Giron, A. Lopez, J. Ciudad, and J.F. San Miguel Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption Hepatology 25 1997 1096 1100
49. Z. Tian, Y. Chen, and B. Gao Natural killer cells in liver disease Hepatology 57 2013 1654 1662
50. L. Munoz, A. Albillos, M. Nieto, E. Reyes, L. Lledo, and J. Monserrat Mesenteric Th1 polarization and monocyte TNF-alpha production: first steps to systemic inflammation in rats with cirrhosis Hepatology 42 2005 411 419
51. L. Munoz, M.J. Borrero, M. Ubeda, M. Lario, D. Diaz, and R. Frances Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosis Hepatology 56 2012 1861 1869
52. M. Ubeda, L. Munoz, M.J. Borrero, D. Diaz, R. Frances, and J. Monserrat Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis Hepatology 52 2010 2086 2095
53. L. Muñoz, M.J. Borrero, M. Ubeda, M. Lario, D. Díaz, and E. Aguado-Fraile Commensal gut flora drives the expansion of proinflammatory T cells in the small intestinal mucosa in rats with CCl4 cirrhosis Hepatology 58 2013 985A
54. J. Du Plessis, H. Vanheel, C.E. Janssen, L. Roos, T. Slavik, and P.I. Stivaktas Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function J Hepatol 58 2013 1125 1132
55. Z. Teltschik, R. Wiest, J. Beisner, S. Nuding, C. Hofmann, and J. Schoelmerich Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense Hepatology 55 2012 1154 1163
56. A.W. Yan, D.E. Fouts, J. Brandl, P. Starkel, M. Torralba, and E. Schott Enteric dysbiosis associated with a mouse model of alcoholic liver disease Hepatology 53 2011 96 105
57. K.A. Tazi, J.J. Quioc, V. Saada, A. Bezeaud, D. Lebrec, and R. Moreau Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M J Hepatol 45 2006 280 289
58. S. Gandoura, E. Weiss, P.E. Rautou, M. Fasseu, T. Gustot, and F. Lemoine Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis J Hepatol 58 2013 936 948
59. A. Lemmers, C. Moreno, T. Gustot, R. Marechal, D. Degre, and P. Demetter The interleukin-17 pathway is involved in human alcoholic liver disease Hepatology 49 2009 646 657
60. H.Q. Sun, J.Y. Zhang, H. Zhang, Z.S. Zou, F.S. Wang, and J.H. Jia Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis J Viral Hepat 19 2012 396 403
61. J.A. Giron, M. Alvarez-Mon, J.L. Menendez-Caro, L. Abreu, A. Albillos, and L. Manzano Increased spontaneous and lymphokine-conditioned IgA and IgG synthesis by B cells from alcoholic cirrhotic patients Hepatology 16 1992 664 670
62. J. Deviere, J. Content, C. Denys, P. Vandenbussche, L. Schandene, and J. Wybran High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production Clin Exp Immunol 77 1989 221 225
63. F.Y. Lee, R.H. Lu, Y.T. Tsai, H.C. Lin, M.C. Hou, and C.P. Li Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation Scand J Gastroenterol 31 1996 500 505
64. W. Zhang, B. Yue, G.Q. Wang, and S.L. Lu Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis Hepatobiliary Pancreat Dis Int 1 2002 577 580
65. J.A. Giron-Gonzalez, C. Martinez-Sierra, C. Rodriguez-Ramos, M.A. Macias, P. Rendon, and F. Diaz Implication of inflammation-related cytokines in the natural history of liver cirrhosis Liver Int 24 2004 437 445
66. J. Deviere, J. Content, C. Denys, P. Vandenbussche, L. Schandene, and J. Wybran Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis Hepatology 11 1990 628 634
67. O. Le Moine, T. Soupison, P. Sogni, A. Marchant, R. Moreau, and A. Hadengue Plasma endotoxin and tumor necrosis factor-alpha in the hyperkinetic state of cirrhosis J Hepatol 23 1995 391 395
68. R. Wiest, S. Das, G. Cadelina, G. Garcia-Tsao, S. Milstien, and R.J. Groszmann Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility J Clin Invest 104 1999 1223 1233
69. J. Genesca, R. Marti, A. Gonzalez, M. Torregrosa, and R. Segura Soluble interleukin-6 receptor levels in liver cirrhosis Am J Gastroenterol 94 1999 3074 3075
70. J.C. Lopez-Talavera, A. Levitzki, M. Martinez, A. Gazit, R. Esteban, and J. Guardia Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites J Clin Invest 100 1997 664 670
71. H. Tilg, A. Wilmer, W. Vogel, M. Herold, B. Nolchen, and G. Judmaier Serum levels of cytokines in chronic liver diseases Gastroenterology 103 1992 264 274
72. O. Ludwiczek, E. Vannier, A. Moschen, A. Salazar-Montes, I. Borggraefe, and C. Gabay Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease Scand J Gastroenterol 43 2008 1360 1365
73. O. Ludwiczek, A. Kaser, D. Novick, C.A. Dinarello, M. Rubinstein, and W. Vogel Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease J Clin Immunol 22 2002 331 337
74. V. von Baehr, W.D. Docke, M. Plauth, C. Liebenthal, S. Kupferling, and H. Lochs Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation Gut 47 2000 281 287
75. B. Byl, I. Roucloux, A. Crusiaux, E. Dupont, and J. Deviere Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients Gastroenterology 104 1993 1492 1497
76. J.A. Giron-Gonzalez, C. Martinez-Sierra, C. Rodriguez-Ramos, P. Rendon, M.A. Macias, and C. Fernandez-Gutierrez Adhesion molecules as a prognostic marker of liver cirrhosis Scand J Gastroenterol 40 2005 217 224
77. A. Kaser, O. Ludwiczek, P. Waldenberger, W. Jaschke, W. Vogel, and H. Tilg Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting Liver 22 2002 380 387
78. J. Trebicka, A. Krag, S. Gansweid, P. Schiedermaier, H.M. Strunk, and R. Fimmers Soluble TNF-alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis and portal hypertension PLoS One 8 2013 e83341
79. M. Buck, G. Garcia-Tsao, R.J. Groszmann, C. Stalling, N.D. Grace, and A.K. Burroughs Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients Hepatology 59 2014 1052 1059
80. S. Wiese, C. Mortensen, J.P. Gotze, E. Christensen, O. Andersen, and F. Bendtsen Cardiac and proinflammatory markers predict prognosis in cirrhosis Liver Int 34 2013 e19 30
81. F. Grunhage, B. Rezori, M. Neef, F. Lammert, T. Sauerbruch, and U. Spengler Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death Clin Gastroenterol Hepatol 6 2008 1255 1262
82. H. Tilg, W. Vogel, C.J. Wiedermann, L. Shapiro, M. Herold, and G. Judmaier Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease Hepatology 18 1993 1132 1138
83. A.S. Eriksson, C. Gretzer, and S. Wallerstedt Elevation of cytokines in peritoneal fluid and blood in patients with liver cirrhosis Hepatogastroenterology 51 2004 505 509
84. A. Albillos, A. de la Hera, M. Gonzalez, J.L. Moya, J.L. Calleja, and J. Monserrat Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement Hepatology 37 2003 208 217
85. A. Lemmers, T. Gustot, A. Durnez, S. Evrard, C. Moreno, and E. Quertinmont An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease Clin Exp Immunol 156 2009 518 527
86. O. Le Moine, J. Deviere, J.M. Devaster, A. Crusiaux, F. Durand, and J. Bernuau Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis J Hepatol 20 1994 819 824
87. I. Mackenzie, and J. Woodhouse C-reactive protein concentrations during bacteraemia: a comparison between patients with and without liver dysfunction Intensive Care Med 32 2006 1344 1351
88. C. Guarner, G. Soriano, A. Tomas, O. Bulbena, M.T. Novella, and J. Balanzo Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia Hepatology 18 1993 1139 1143
89. B. Campillo, P.N. Bories, C. Benvenuti, and C. Dupeyron Serum and urinary nitrate levels in liver cirrhosis: endotoxemia, renal function and hyperdynamic circulation J Hepatol 25 1996 707 714
90. R.S. Lin, F.Y. Lee, S.D. Lee, Y.T. Tsai, H.C. Lin, and R.H. Lu Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation J Hepatol 22 1995 165 172
91. J.M. Gonzalez-Navajas, P. Bellot, R. Frances, P. Zapater, C. Munoz, and J.C. Garcia-Pagan Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin J Hepatol 48 2008 61 67
92. K.A. Tazi, R. Moreau, P. Herve, A. Dauvergne, D. Cazals-Hatem, and F. Bert Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: role of Akt signaling Gastroenterology 129 2005 303 314
93. S.M. Riordan, N. Skinner, A. Nagree, H. McCallum, C.J. McIver, and J. Kurtovic Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis Hepatology 37 2003 1154 1164
94. T. Manigold, U. Bocker, C. Hanck, J. Gundt, P. Traber, and C. Antoni Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis Eur J Gastroenterol Hepatol 15 2003 275 282
95. I. Cirera, T.M. Bauer, M. Navasa, J. Vila, L. Grande, and P. Taura Bacterial translocation of enteric organisms in patients with cirrhosis J Hepatol 34 2001 32 37
96. G. Garcia-Tsao, F.Y. Lee, G.E. Barden, R. Cartun, and A.B. West Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites Gastroenterology 108 1995 1835 1841
97. M. Perez-Paramo, J. Munoz, A. Albillos, I. Freile, F. Portero, and M. Santos Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites Hepatology 31 2000 43 48
98. R. Wiest, M. Lawson, and M. Geuking Pathological bacterial translocation in liver cirrhosis J Hepatol 60 2014 197 209
99. A.S. Mehta, R.E. Long, M.A. Comunale, M. Wang, L. Rodemich, and J. Krakover Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis J Virol 82 2008 1259 1270
100. M. Papp, G.L. Norman, Z. Vitalis, I. Tornai, I. Altorjay, and I. Foldi Presence of anti-microbial antibodies in liver cirrhosis - a tell-tale sign of compromised immunity? PLoS One 5 2010 e12957
101. L. Vallat, Y. Benhamou, M. Gutierrez, P. Ghillani, C. Hercher, and V. Thibault Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection Arthritis Rheum 50 2004 3668 3678
102. C. Fazi, A. Dagklis, F. Cottini, L. Scarfo, M.T. Bertilaccio, and R. Finazzi Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals Cytometry B Clin Cytom 78 2010 S61 68
103. P. Kubes, and W.Z. Mehal Sterile inflammation in the liver Gastroenterology 143 2012 1158 1172
104. B.V. Martin-Murphy, M.P. Holt, and C. Ju The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice Toxicol Lett 192 2010 387 394
105. J. Petrasek, S. Bala, T. Csak, D. Lippai, K. Kodys, and V. Menashy IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice J Clin Invest 122 2012 3476 3489
106. P. Zhu, L. Duan, J. Chen, A. Xiong, Q. Xu, and H. Zhang Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice Hum Gene Ther 22 2011 853 864
107. B. Appenrodt, F. Grunhage, M.G. Gentemann, L. Thyssen, T. Sauerbruch, and F. Lammert Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis Hepatology 51 2010 1327 1333
108. T. Bruns, J. Peter, P.A. Reuken, D.H. Grabe, S.R. Schuldes, and J. Brenmoehl NOD2 gene variants are a risk factor for culture-positive spontaneous bacterial peritonitis and monomicrobial bacterascites in cirrhosis Liver Int 32 2012 223 230
109. T. Reiberger, A. Ferlitsch, B.A. Payer, M. Mandorfer, B.B. Heinisch, and H. Hayden Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis J Hepatol 58 2013 911 921
110. H.D. Nischalke, C. Berger, K. Aldenhoff, L. Thyssen, M. Gentemann, and F. Grunhage Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis J Hepatol 55 2011 1010
111. T. Bruns, P.A. Reuken, J. Fischer, T. Berg, and A. Stallmach Further evidence for the relevance of TLR2 gene variants in spontaneous bacterial peritonitis J Hepatol 56 2012 1207 1208 [author reply 1208-1209]
112. S.K. Biswas, and E. Lopez-Collazo Endotoxin tolerance: new mechanisms, molecules and clinical significance Trends Immunol 30 2009 475 487
113. N. Coant, M. Simon-Rudler, T. Gustot, M. Fasseu, S. Gandoura, and K. Ragot Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis J Hepatol 55 2011 784 793
114. A. Galbois, D. Thabut, K.A. Tazi, M. Rudler, M.S. Mohammadi, and D. Bonnefont-Rousselot Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis Hepatology 49 2009 175 184
115. J. Fernandez, L. Ruiz del Arbol, C. Gomez, R. Durandez, R. Serradilla, and C. Guarner Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage Gastroenterology 131 2006 1049 1056 [quiz 1285]
116. H.E. Wasmuth, D. Kunz, E. Yagmur, A. Timmer-Stranghoner, D. Vidacek, and E. Siewert Patients with acute on chronic liver failure display "sepsis-like" immune paralysis J Hepatol 42 2005 195 201
117. M.L. Berres, B. Schnyder, E. Yagmur, B. Inglis, S. Stanzel, and J.J. Tischendorf Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis Liver Int 29 2009 536 543
118. P.A. Berry, C.G. Antoniades, I. Carey, M.J. McPhail, M.J. Hussain, and E.T. Davies Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis Intensive Care Med 37 2011 453 460
119. T. Xing, L. Li, H. Cao, and J. Huang Altered immune function of monocytes in different stages of patients with acute on chronic liver failure Clin Exp Immunol 47 2007 184 188
120. V. Arvaniti, G. D'Amico, G. Fede, P. Manousou, E. Tsochatzis, and M. Pleguezuelo Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis Gastroenterology 139 2010 1246-1256, 1256 e1241-1245
121. R. Moreau, R. Jalan, P. Gines, M. Pavesi, P. Angeli, J. Cordoba CANONIC Study Investigators of the EASL-CLIF Consortium Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis Gastroenterology 144 2013 1426-1437, 1437 e1421-1429
122. A. Albillos, A. de-la-Hera, and M. Alvarez-Mon Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites Lancet 363 2004 1608 1610
123. M. Papp, N. Sipeki, Z. Vitalis, T. Tornai, I. Altorjay, and I. Tornai High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis J Hepatol 59 2013 457 466
124. T.M. McCashland, L.C. Preheim, and M.J. Gentry Pneumococcal vaccine response in cirrhosis and liver transplantation J Infect Dis 181 2000 757 760
125. Y. Iwakiri, and R.J. Groszmann The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule Hepatology 43 2006 S121 131
126. P. Bellot, J.C. Garcia-Pagan, R. Frances, J.G. Abraldes, M. Navasa, and M. Perez-Mateo Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis Hepatology 52 2010 2044 2052
127. B. Rasaratnam, D. Kaye, G. Jennings, F. Dudley, and J. Chin-Dusting The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial Ann Intern Med 139 2003 186 193
128. G. Wright, N.A. Davies, D.L. Shawcross, S.J. Hodges, C. Zwingmann, and H.F. Brooks Endotoxemia produces coma and brain swelling in bile duct ligated rats Hepatology 45 2007 1517 1526
129. R. Jover, R. Rodrigo, V. Felipo, R. Insausti, J. Saez-Valero, and M.S. Garcia-Ayllon Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: a model of hepatic encephalopathy in cirrhosis Hepatology 43 2006 1257 1266
130. S.M. Kerfoot, C. D'Mello, H. Nguyen, M.N. Ajuebor, P. Kubes, and T. Le TNF-alpha-secreting monocytes are recruited into the brain of cholestatic mice Hepatology 43 2006 154 162
131. R. Kalakeche, T. Hato, G. Rhodes, K.W. Dunn, T.M. El-Achkar, and Z. Plotkin Endotoxin uptake by S1 proximal tubular segment causes oxidative stress in the downstream S2 segment J Am Soc Nephrol 22 2011 1505 1516
132. R. Murugan, V. Karajala-Subramanyam, M. Lee, S. Yende, L. Kong, and M. Carter Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival Kidney Int 77 2010 527 535
133. H. Gomez, C. Ince, D. De Backer, P. Pickkers, D. Payen, and J. Hotchkiss A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury Shock 41 2014 3 11